Plasmodium falciparum: Immunogenicity of Alum-Adsorbed Clinical-Grade TBV25–28, a Yeast-Secreted Malaria Transmission-Blocking Vaccine Candidate
- 28 February 2001
- journal article
- Published by Elsevier in Experimental Parasitology
- Vol. 97 (2), 61-69
- https://doi.org/10.1006/expr.2000.4580
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoesMolecular and Biochemical Parasitology, 1995
- Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparumMolecular and Biochemical Parasitology, 1993
- Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals.The Journal of Experimental Medicine, 1991
- A vaccine candidate from the sexual stage of human malaria that contains EGF-like domainsNature, 1988
- An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunityJournal of Immunological Methods, 1986
- Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito.The Journal of Experimental Medicine, 1985
- Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum.The Journal of Experimental Medicine, 1983
- Malaria: Successful Immunization Against the Sexual Stages of Plasmodium gallinaceumScience, 1976
- Malaria transmission blocked by immunisation with gametes of the malaria parasiteNature, 1976